These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6233767)

  • 1. Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion.
    Okazaki H; Takahashi H; Miura K; Ishizaki M; Taguchi Y
    Transplantation; 1984 May; 37(5):523-5. PubMed ID: 6233767
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplant outcome with donor specific buffy-coat and lymphocyte-transfused patients.
    Okazaki H; Takahashi H; Jimbo M; Iguro T; Satoh T; Ishizak M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1832-3. PubMed ID: 2652595
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of donor specific blood transfusions in prolongation of kidney graft survival.
    Matsumoto T; Sakagami K; Orita K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2264-7. PubMed ID: 2950636
    [No Abstract]   [Full Text] [Related]  

  • 4. Pretransplant platelet transfusions: their effects on renal allograft outcome and mixed lymphocyte culture reactivity.
    Cahen R; Friedel AC; Betuel H; Adeleine P; Robert F; Trolliet P; Francois B
    Transplantation; 1993 Jun; 55(6):1428-31. PubMed ID: 8516830
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine.
    Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596
    [No Abstract]   [Full Text] [Related]  

  • 6. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
    Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
    Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation.
    Bean MA; Mickelson E; Yanagida J; Ishioka S; Hansen JA
    Transplant Proc; 1988 Dec; 20(6):1084-6. PubMed ID: 2974196
    [No Abstract]   [Full Text] [Related]  

  • 9. Related donor kidney transplantation is the best form of treatment for uremia.
    Groth CG; Fehrman I; Ringdén O; Lundgren G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of different transfusion policies on the results of related live transplantation donors sharing a haplotype].
    Morales J; James E; Mocarquer A; Zehnder C; Aris L; Rodríguez O; Aguilo J
    Rev Med Chil; 1985 Dec; 113(12):1170-4. PubMed ID: 3915579
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of donor-specific blood transfusion on the survival of living related renal grafts.
    Akiyama N; Otsubo O; Yamauchi J; Sugimoto H; Tomikawa S; Takeda Y; Degawa H; Maeda T; Kawaguchi H; Imai T
    Jpn J Exp Med; 1984 Oct; 54(5):225-7. PubMed ID: 6398837
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of canine cardiac allograft survival using donor-specific buffy coat pretransfusions.
    Kurlansky PA; Dresdale AR; Pierson R; McManus RP; Michler RE; Sachs H; Thomas WG; Lau H; Hardy MA; Marboe C
    Transplantation; 1986 Jul; 42(1):98-101. PubMed ID: 3523892
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of allograft function to the development of donor specific cellular nonreactivity in human cadaveric allograft recipients.
    Rashid A; Sengar DP; Couture RA; Harris JE
    Trans Am Soc Artif Intern Organs; 1976; 22():229-33. PubMed ID: 133496
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients.
    Lenhard V; Massen G; Seifert P; Johannsen R; Grosse-Wilde H
    Transplant Proc; 1982 Jun; 14(2):329-32. PubMed ID: 6214060
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Rubin AL; Stenzel KH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1023. PubMed ID: 1989145
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixed lymphocyte culture responses. Lack of correlation with cadaveric renal allograft survival and blood transfusions.
    Jeffery JR; Cheung K; Masniuk J; Taylor D
    Transplantation; 1984 Jul; 38(1):42-5. PubMed ID: 6234685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged graft survival by donor-specific blood transfusion (DSBT).
    Takahashi I; Otsubo O; Nishimura M; Maeda T; Yanagisawa T; Nozaki H; Sugimoto H; Kusaba Y; Yamada Y; Yamauchi J; Sakai A; Inou T
    Transplant Proc; 1982 Jun; 14(2):367-9. PubMed ID: 7051481
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
    Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ
    Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three year experience of donor specific transfusion and concomitant cyclosporine A.
    Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.